Healthcare provider profile · identity verified

Eric J Lehman, M.D.

Family Practice · ARCHBOLD, OH · NPI 1164464046

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	417	114
Losartan Potassium	Losartan Potassium	320	79
Lisinopril	Lisinopril	298	86
Metformin Hcl	Metformin Hcl	212	57
Levothyroxine Sodium	Levothyroxine Sodium	210	50
Amlodipine Besylate	Amlodipine Besylate	203	53
Metoprolol Succinate	Metoprolol Succinate	187	52
Hydrochlorothiazide	Hydrochlorothiazide	168	49
Carvedilol	Carvedilol	162	41
Omeprazole	Omeprazole	162	45
Glimepiride	Glimepiride	146	39
Eliquis	Apixaban	139	28
Tamsulosin Hcl	Tamsulosin Hcl	138	45
Pantoprazole Sodium	Pantoprazole Sodium	136	33
Metoprolol Tartrate	Metoprolol Tartrate	134	34
Gabapentin	Gabapentin	131	30
Furosemide	Furosemide	125	39
Pravastatin Sodium	Pravastatin Sodium	111	29
Jardiance	Empagliflozin	106	23
Clopidogrel	Clopidogrel Bisulfate	97	26
Trazodone Hcl	Trazodone Hcl	90	23
Meloxicam	Meloxicam	78	28
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	76	20
Potassium Chloride	Potassium Chloride	76	19
Simvastatin	Simvastatin	76	20
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	75	24
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	73	11
Duloxetine Hcl	Duloxetine Hcl	72	12
Cephalexin	Cephalexin	71	48
Allopurinol	Allopurinol	69	16
Bumetanide	Bumetanide	69	suppressed
Citalopram Hbr	Citalopram Hydrobromide	67	22
Escitalopram Oxalate	Escitalopram Oxalate	64	14
Montelukast Sodium	Montelukast Sodium	64	13
Warfarin Sodium	Warfarin Sodium	61	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	59	16
Albuterol Sulfate Hfa	Albuterol Sulfate	58	22
Rosuvastatin Calcium	Rosuvastatin Calcium	58	17
Amitriptyline Hcl	Amitriptyline Hcl	56	13
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	56	18
Spironolactone	Spironolactone	56	13
Mirtazapine	Mirtazapine	55	12
Fluticasone Propionate	Fluticasone Propionate	51	13
Hydralazine Hcl	Hydralazine Hcl	51	12
Alendronate Sodium	Alendronate Sodium	47	suppressed
Prednisone	Prednisone	46	36
Ropinirole Hcl	Ropinirole Hcl	46	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	43	13
Sertraline Hcl	Sertraline Hcl	41	11
Sumatriptan Succinate	Sumatriptan Succinate	41	suppressed
Amiodarone Hcl	Amiodarone Hcl	40	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	40	26
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	38	23
Memantine Hcl	Memantine Hcl	37	suppressed
Famotidine	Famotidine	35	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	35	11
Sucralfate	Sucralfate	34	suppressed
Paroxetine Hcl	Paroxetine Hcl	33	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	32	26
Isosorbide Mononitrate Er	Isosorbide Mononitrate	32	suppressed
Lorazepam	Lorazepam	32	11
Atenolol	Atenolol	30	suppressed
Ezetimibe	Ezetimibe	29	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	29	16
Lamotrigine	Lamotrigine	29	suppressed
Xarelto	Rivaroxaban	29	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	28	11
Ibuprofen	Ibuprofen	28	12
Lovastatin	Lovastatin	27	suppressed
Rivastigmine	Rivastigmine	27	suppressed
Amoxicillin	Amoxicillin	26	19
Metformin Hcl Er	Metformin Hcl	26	suppressed
Alprazolam	Alprazolam	24	17
Buspirone Hcl	Buspirone Hcl	24	suppressed
Finasteride	Finasteride	24	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	24	suppressed
Azithromycin	Azithromycin	23	19
Klor-Con M20	Potassium Chloride	23	suppressed
Synthroid	Levothyroxine Sodium	23	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	22	16
Carbidopa-Levodopa	Carbidopa/Levodopa	22	suppressed
Nystatin	Nystatin	22	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	21	suppressed
Topiramate	Topiramate	21	suppressed
Estradiol	Estradiol	20	suppressed
Tramadol Hcl	Tramadol Hcl	20	suppressed
Cefdinir	Cefdinir	19	18
Lansoprazole	Lansoprazole	19	suppressed
Meclizine Hcl	Meclizine Hcl	19	14
Nitroglycerin	Nitroglycerin	19	15
Donepezil Hcl	Donepezil Hcl	18	suppressed
Celecoxib	Celecoxib	17	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	17	suppressed
Irbesartan	Irbesartan	17	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	17	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	16	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	16	suppressed
Etodolac	Etodolac	16	suppressed
Labetalol Hcl	Labetalol Hcl	16	suppressed
Nabumetone	Nabumetone	16	suppressed
Propranolol Hcl Er	Propranolol Hcl	16	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	15	13
Quetiapine Fumarate	Quetiapine Fumarate	15	suppressed
Entresto	Sacubitril/Valsartan	14	suppressed
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	14	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	14	suppressed
Levetiracetam	Levetiracetam	13	suppressed
Myrbetriq	Mirabegron	13	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	13	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	12	suppressed
Benztropine Mesylate	Benztropine Mesylate	12	suppressed
Januvia	Sitagliptin Phosphate	12	suppressed
Symbicort	Budesonide/Formoterol Fumarate	12	suppressed
Verapamil Sr	Verapamil Hcl	12	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	11	suppressed
Clonidine Hcl	Clonidine Hcl	11	suppressed
Diclofenac Sodium	Diclofenac Sodium	11	suppressed
Methotrexate	Methotrexate Sodium	11	suppressed
Metronidazole	Metronidazole	11	suppressed
Mupirocin	Mupirocin	11	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	11	suppressed
Pregabalin	Pregabalin	11	suppressed
Risperidone	Risperidone	11	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error